Chemical Compound Review:
PubChem17487 1,3-thiazolidine-2,4-dione
Synonyms:
ARONIS23865, CHEMBL85398, NSC-6745, ACMC-1ANE1, AG-B-76923, ...
Digby,
Montague,
Sewter,
Sanders,
Wilkison,
O'Rahilly,
Prins,
Lebovic,
Kir,
Casey,
Kroll,
Sarraf,
Pecciarini,
Chen,
Mueller,
Spiegelman,
Fletcher,
Unger,
Graham,
Drinkard,
Shatin,
Tsong,
Burgess,
Cuzzocrea,
Pisano,
Dugo,
Ianaro,
Maffia,
Patel,
Di Paola,
Ialenti,
Genovese,
Chatterjee,
Di Rosa,
Caputi,
Thiemermann,
Lebovitz,
Kreider,
Freed,
Zhang,
Berger,
Zhou,
Elbrecht,
Biswas,
White-Carrington,
Szalkowski,
Moller,
Dornhorst,
Yee,
Williams,
Wen,
Young,
Lester,
Johnson,
Farrar,
Walker,
Povoski,
Suster,
Eng,
Vidal-Puig,
Considine,
Jimenez-Liñan,
Werman,
Pories,
Caro,
Flier,
- Liver enzyme monitoring in patients treated with troglitazone. Graham, D.J., Drinkard, C.R., Shatin, D., Tsong, Y., Burgess, M.J. JAMA (2001)
- Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Young, P.W., Cawthorne, M.A., Coyle, P.J., Holder, J.C., Holman, G.D., Kozka, I.J., Kirkham, D.M., Lister, C.A., Smith, S.A. Diabetes (1995)
- Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Nolan, J.J., Olefsky, J.M., Nyce, M.R., Considine, R.V., Caro, J.F. Diabetes (1996)
- Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Crawford, R.S., Mudaliar, S.R., Henry, R.R., Chait, A. Diabetes (1999)
- Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directions. Roberts, A.W., Thomas, A., Rees, A., Evans, M. Curr. Opin. Lipidol. (2003)
- Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice. Galea, E., Feinstein, D.L., Lacombe, P. Diabetologia (2006)
- Thiazolidinediones and insulin: rationale for use and role of combination therapy in type 2 diabetes mellitus. Huang, A., Raskin, P. Treatments in endocrinology. (2005)
- 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., Evans, R.M. Cell (1995)
- The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Moore, K.J., Rosen, E.D., Fitzgerald, M.L., Randow, F., Andersson, L.P., Altshuler, D., Milstone, D.S., Mortensen, R.M., Spiegelman, B.M., Freeman, M.W. Nat. Med. (2001)
- PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Kroll, T.G., Sarraf, P., Pecciarini, L., Chen, C.J., Mueller, E., Spiegelman, B.M., Fletcher, J.A. Science (2000)
- Terminal differentiation of human breast cancer through PPAR gamma. Mueller, E., Sarraf, P., Tontonoz, P., Evans, R.M., Martin, K.J., Zhang, M., Fletcher, C., Singer, S., Spiegelman, B.M. Mol. Cell (1998)
- Search for the preadipocyte progenitor cell. Hausman, G.J., Hausman, D.B. J. Clin. Invest. (2006)
- Pilot Study of Rosiglitazone Therapy in Women with Breast Cancer: Effects of Short-term Therapy on Tumor Tissue and Serum Markers. Yee, L.D., Williams, N., Wen, P., Young, D.C., Lester, J., Johnson, M.V., Farrar, W.B., Walker, M.J., Povoski, S.P., Suster, S., Eng, C. Clin. Cancer Res. (2007)
- Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Schoppee, P.D., Garmey, J.C., Veldhuis, J.D. Biol. Reprod. (2002)
- Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study. Roberts, V.L., Stewart, J., Issa, M., Lake, B., Melis, R. Clinical therapeutics. (2005)
- Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Lebovic, D.I., Kir, M., Casey, C.L. Fertil. Steril. (2004)
- Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Maffia, P., Patel, N.S., Di Paola, R., Ialenti, A., Genovese, T., Chatterjee, P.K., Di Rosa, M., Caputi, A.P., Thiemermann, C. Eur. J. Pharmacol. (2004)
- Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Guan, H.P., Ishizuka, T., Chui, P.C., Lehrke, M., Lazar, M.A. Genes Dev. (2005)
- Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Vidal-Puig, A.J., Considine, R.V., Jimenez-Liñan, M., Werman, A., Pories, W.J., Caro, J.F., Flier, J.S. J. Clin. Invest. (1997)
- Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. De Vos, P., Lefebvre, A.M., Miller, S.G., Guerre-Millo, M., Wong, K., Saladin, R., Hamann, L.G., Staels, B., Briggs, M.R., Auwerx, J. J. Clin. Invest. (1996)
- Insulinotropic meglitinide analogues. Dornhorst, A. Lancet (2001)
- Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest. Lu, M., Kwan, T., Yu, C., Chen, F., Freedman, B., Schafer, J.M., Lee, E.J., Jameson, J.L., Jordan, V.C., Cryns, V.L. J. Biol. Chem. (2005)
- IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Bendixen, A.C., Shevde, N.K., Dienger, K.M., Willson, T.M., Funk, C.D., Pike, J.W. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Digby, J.E., Montague, C.T., Sewter, C.P., Sanders, L., Wilkison, W.O., O'Rahilly, S., Prins, J.B. Diabetes (1998)
- Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression. Brunmair, B., Gras, F., Neschen, S., Roden, M., Wagner, L., Waldhäusl, W., Fürnsinn, C. Diabetes (2001)
- Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. Zhang, B., Berger, J., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D., Moller, D.E. J. Biol. Chem. (1996)
- A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. Gurnell, M., Wentworth, J.M., Agostini, M., Adams, M., Collingwood, T.N., Provenzano, C., Browne, P.O., Rajanayagam, O., Burris, T.P., Schwabe, J.W., Lazar, M.A., Chatterjee, V.K. J. Biol. Chem. (2000)
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. Law, R.E., Meehan, W.P., Xi, X.P., Graf, K., Wuthrich, D.A., Coats, W., Faxon, D., Hsueh, W.A. J. Clin. Invest. (1996)
- Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Muto, S., Aiba, A., Saito, Y., Nakao, K., Nakamura, K., Tomita, K., Kitamura, T., Kurabayashi, M., Nagai, R., Higashihara, E., Harris, P.C., Katsuki, M., Horie, S. Hum. Mol. Genet. (2002)
- Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha. Kockx, M., Gervois, P.P., Poulain, P., Derudas, B., Peters, J.M., Gonzalez, F.J., Princen, H.M., Kooistra, T., Staels, B. Blood (1999)
- Thiazolidinedione treatment enhances insulin effects on protein kinase C-zeta /lambda activation and glucose transport in adipocytes of nondiabetic and Goto-Kakizaki type II diabetic rats. Kanoh, Y., Bandyopadhyay, G., Sajan, M.P., Standaert, M.L., Farese, R.V. J. Biol. Chem. (2000)
- Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB1 with type 2 diabetes. Sun, M.W., Lee, J.Y., de Bakker, P.I., Burtt, N.P., Almgren, P., Råstam, L., Tuomi, T., Gaudet, D., Daly, M.J., Hirschhorn, J.N., Altshuler, D., Groop, L., Florez, J.C. Diabetes (2006)
- Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Kallen, C.B., Lazar, M.A. Proc. Natl. Acad. Sci. U.S.A. (1996)
- ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Kim, J.B., Wright, H.M., Wright, M., Spiegelman, B.M. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Fasshauer, M., Klein, J., Kriauciunas, K.M., Ueki, K., Benito, M., Kahn, C.R. Mol. Cell. Biol. (2001)
- Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. Adams, M., Reginato, M.J., Shao, D., Lazar, M.A., Chatterjee, V.K. J. Biol. Chem. (1997)
- Lipotoxic diseases. Unger, R.H. Annu. Rev. Med. (2002)
- Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs. Xu, Y., Lu, L., Greyson, C., Lee, J., Gen, M., Kinugawa, K., Long, C.S., Schwartz, G.G. Diabetes (2003)
- Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction. Lebovitz, H.E., Kreider, M., Freed, M.I. Diabetes Care (2002)
- Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes. Hsueh, W.A., Jackson, S., Law, R.E. Diabetes Care (2001)
- Identification of a functional peroxisome proliferator-activated receptor responsive element within the murine perilipin gene. Nagai, S., Shimizu, C., Umetsu, M., Taniguchi, S., Endo, M., Miyoshi, H., Yoshioka, N., Kubo, M., Koike, T. Endocrinology (2004)